Evaluation of the Impact of Embryo Biopsy on the Reproductive Potential of Embryos Undergoing In Vitro Fertilization (IVF)

Completed

Conditions studied: Each Patient is Both Case and Control, 1 Embryo Will be Biopsied and 1 Embryo is Not

In brief

To assess the impact of embryo biopsy on the reproductive potential of human embryos.

Key facts

Study ID

NCT01219504

Run by

Reproductive Medicine Associates of New Jersey

People needed

200

Starts

2008-04-01

Expected to finish

2012-09-01

Last updated by the study team

2013-01-23

Who can join

Age: 18 and older, up to 35. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Maximum of one prior failed IVF treatment cycle
• Female partner less than 35 years of age
• Normal day 3 FSH level (<10 miu/mL)
• Total basal antral follicle count greater than or equal to 12
• Male partner with greater than 100,000 total motile spermatozoa and at least 1% normal forms
• Body mass index (BMI) < or = 32
• Normal uterine cavity

You may not qualify if…

• Diagnosis of chronic anovulation secondary to polycystic ovarian disease
• Diagnosis of endometrial insufficiency
• Clinical indication for pre-implantation genetic diagnosis (PGD) (undergoing IVF with PGD to rule out a known genetic defect)
• Use of testicular aspiration or biopsy procedures to obtain sperm

Where it is running

• Reproductive Medicine Associates of Connecticut — Norfolk, Connecticut, United States
• Reproductive Medicine Associates of New Jersey — Morristown, New Jersey, United States
• Reproductive Medicine Associates of New York — New York, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.